University Hospitals Case Medical Center, Case Western Reserve University
- Advisory Board: AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson ; KemPharm; Novartis Pharmaceutical Corporation; Noven Pharmaceuticals; Organon Pharmaceuticals USA Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Sepracor Inc.; Shire Pharmaceuticals Inc.; Solvay Pharmaceuticals; Supernus Pharmaceuticals, Inc.; Validus Pharmaceuticals; Wyeth Pharmaceuticals; sanofi-aventis
- Consultant: Abbott Laboratories; Addrenex Pharmaceuticals, Inc.; AstraZeneca LP; Biovail Corporation; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; H. Lundbeck A/S; Johnson & Johnson ; KemPharm; Novartis Pharmaceutical Corporation; Noven Pharmaceuticals; Organon Pharmaceuticals USA Inc.; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Sepracor Inc.; Shire Pharmaceuticals Inc.; Solvay Pharmaceuticals; Supernus Pharmaceuticals, Inc.; Validus Pharmaceuticals; Wyeth Pharmaceuticals; sanofi-aventis
- Grant Support: Abbott Laboratories; Addrenex Pharmaceuticals, Inc.; AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson ; Neuropharm Group plc; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Shire Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Wyeth Pharmaceuticals
- Research Support: Abbott Laboratories; Addrenex Pharmaceuticals, Inc.; AstraZeneca LP; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; GlaxoSmithKline; Johnson & Johnson ; Neuropharm Group plc; Otsuka America Pharmaceutical, Inc.; Pfizer Inc; Shire Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Wyeth Pharmaceuticals
- Speakers Bureau: Bristol-Myers Squibb; Johnson & Johnson ; Shire Pharmaceuticals Inc.